Citation Impact
Citing Papers
Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America
2010 Standout
Systematic development of ionizable lipid nanoparticles for placental mRNA delivery using a design of experiments approach
2023 StandoutNobel
Vincristine-induced peripheral neuropathy in children with cancer: A systematic review
2017
Cancer nanomedicine: progress, challenges and opportunities
2016 Standout
Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour
2006 Standout
Nano based drug delivery systems: recent developments and future prospects
2018 Standout
Vincristine sulfate liposomes injection (Marqibo) in heavily pretreated patients with refractory aggressive non‐Hodgkin lymphoma
2009
Understanding and controlling the interaction of nanomaterials with proteins in a physiological environment
2011
Vincristine: Can its therapeutic index be enhanced?
2009
To PEGylate or not to PEGylate: Immunological properties of nanomedicine’s most popular component, polyethylene glycol and its alternatives
2021
Analysis of anticancer drugs: A review
2011 Standout
Fetal pulse oximetry for fetal assessment in labour
2004
Biomolecular coronas provide the biological identity of nanosized materials
2012 Standout
Liposomal drug delivery systems: From concept to clinical applications
2012 Standout
Quantification of Vincristine and its Major Metabolite in Human Plasma by High-Performance Liquid Chromatography/Tandem Mass Spectrometry
2008
Protein adsorption is required for stealth effect of poly(ethylene glycol)- and poly(phosphoester)-coated nanocarriers
2016 Standout
Interactions of nanoparticles with plasma proteins: implication on clearance and toxicity of drug delivery systems
2011
Antifungal agents: mechanisms of action
2003 Standout
Interfacing Engineered Nanoparticles with Biological Systems: Anticipating Adverse Nano–Bio Interactions
2012
Overview of the lipid formulations of amphotericin B
2002
Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1)
2013 Standout
Antifungal agents and therapy for infants and children with invasive fungal infections: a pharmacological perspective
2012
Fetal pulse oximetry for fetal assessment in labour
2014
Amphotericin B versus fluconazole for controlling fungal infections in neutropenic cancer patients
2014
Human Pharmacogenomic Variations and Their Implications for Antifungal Efficacy
2006
Global and Multi-National Prevalence of Fungal Diseases—Estimate Precision
2017 Standout
Feasibility Investigation of Cellulose Polymers for Mucoadhesive Nasal Drug Delivery Applications
2015
Surface-Enhanced Raman Spectroscopy for Bioanalysis: Reliability and Challenges
2018 Standout
Liposomal Formulations in Clinical Use: An Updated Review
2017 Standout
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Antifungal Therapeutic Drug Monitoring: Established and Emerging Indications
2008
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Strategies to Reduce Mortality in Adult and Neonatal Candidemia in Developing Countries
2017
Nanoparticle Size and Surface Chemistry Determine Serum Protein Adsorption and Macrophage Uptake
2011 Standout
Amphotericin B lipid soluble formulations versus amphotericin B in cancer patients with neutropenia
2014
Plant Secondary Metabolites as Anticancer Agents: Successes in Clinical Trials and Therapeutic Application
2018 Standout
Pharmacokinetics and Pharmacodynamics of Antifungals
2006
Analysis of nanoparticle delivery to tumours
2016 Standout
Cellular uptake of nanoparticles: journey inside the cell
2017 Standout
Works of Christa E. Nath being referenced
Population Pharmacokinetics of Liposomal Amphotericin B in Pediatric Patients with Malignant Diseases
2006
Pre-existing antibodies against polyethylene glycol reduce asparaginase activities on first administration of pegylated <i>E. coli</i> asparaginase in children with acute lymphocytic leukemia
2020
Increasing the dosage of vincristine
2004
HPLC‐fluorescence assay for acyclovir in children
2008
Plasma protein distribution and its impact on pharmacokinetics of liposomal amphotericin B in paediatric patients with malignant diseases
2006
Fetal Oxygen Saturation Monitoring in Labour: An Analysis of 118 Cases
1997
Population pharmacokinetics of amphotericin B in children with malignant diseases
2001
Amphotericin B in Children with Malignant Disease: a Comparison of the Toxicities and Pharmacokinetics of Amphotericin B Administered in Dextrose versus Lipid Emulsion
1999